Canlyniadau Chwilio - Hassan Izzedine

  • Dangos 1 - 20 canlyniadau o 20
Mireinio'r Canlyniadau
  1. 1
    New drug toxicities in the onco-nephrology world

    New drug toxicities in the onco-nephrology world gan Mark A. Perazella, Hassan Izzedine

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Onco-nephrology: an appraisal of the cancer and chronic kidney disease links

    Onco-nephrology: an appraisal of the cancer and chronic kidney disease links gan Hassan Izzedine, Mark A. Perazella

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Anticancer Drug-Induced Acute Kidney Injury

    Anticancer Drug-Induced Acute Kidney Injury gan Hassan Izzedine, Mark A. Perazella

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Adverse kidney effects of epidermal growth factor receptor inhibitors

    Adverse kidney effects of epidermal growth factor receptor inhibitors gan Hassan Izzedine, Mark A. Perazella

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Acute kidney injury in patients with COVID-19: an update on the pathophysiology

    Acute kidney injury in patients with COVID-19: an update on the pathophysiology gan Hassan Izzedine, Kenar D. Jhaveri

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?

    Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial? gan Hassan Izzedine, Marco Bonilla, Kenar D. Jhaveri

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    COVID-19 therapeutic options for patients with kidney disease

    COVID-19 therapeutic options for patients with kidney disease gan Hassan Izzedine, Kenar D. Jhaveri, Mark A. Perazella

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    COVID-19 in Patients Undergoing Hemodialysis: Prevalence and Asymptomatic Screening During a Period of High Community Prevalence in a Large Paris Center

    COVID-19 in Patients Undergoing Hemodialysis: Prevalence and Asymptomatic Screening During a Period of High Community Prevalence in a Large Paris Center gan Caroline Créput, Christine Fumeron, Daniel Tolédano, Mirela Diaconita, Hassan Izzedine

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma

    Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma gan Hassan Izzedine, Lisa Derosa, Gwénaël Le Teuff, Laurence Albigès, Bernard Escudier

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Anticancer Drug-Induced Capillary Leak Syndrome

    Anticancer Drug-Induced Capillary Leak Syndrome gan Hassan Izzedine, Alexis Mathian, Zahir Amoura, Jia Hwei Ng, Kenar D. Jhaveri

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Renal effects of immune checkpoint inhibitors

    Renal effects of immune checkpoint inhibitors gan Hassan Izzedine, Christine Mateus, C. Boutros, Caroline Robert, Philippe Rouvier, Zahir Amoura, Alexis Mathian

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies

    Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies gan Tim Eisen, Cora N. Sternberg, Caroline Robert, Peter F.A. Mulders, L Pyle, S Zbinden, Hassan Izzedine, Bernard Escudier

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study

    Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study gan Johann Cailhol, Béatrice Nkurunziza, Hassan Izzedine, Emmanuel Nindagiye, Laurence Munyana, Evelyne Baramperanye, Janvière Nzorijana, Désiré Sakubu, Théodore Niyongabo, Olivier Bouchaud

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)

    Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF) gan Hassan Izzedine, Bernard Escudier, Catherine Lhommé, Patricia Pautier, Philippe Rouvier, Victor Gueutin, A Baumelou, Lisa Derosa, Rastilav Bahleda, Antoine Hollebecque, Dil Sahali, Jean Charles Soria

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Gemcitabine-induced thrombotic microangiopathy: a systematic review

    Gemcitabine-induced thrombotic microangiopathy: a systematic review gan Hassan Izzedine, Corinne Isnard Bagnis, Vincent Launay‐Vacher, L. Mercadal, Isabelle Tostivint, Olivier Rixe, Isabelle Brochériou, Edward Bourry, S. Karie, S. Saeb, Nadine Casimir, Bertrand Billemont, Gilbert Deray

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

    Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy gan Hassan Izzedine, M. Mangier, Virginie Ory, Shaoyu Zhang, Kélhia Sendeyo, Khedidja Bouachi, Vincent Audard, Christine Péchoux, Jean Charles Soria, Christophe Massard, Rastilav Bahleda, Edward Bourry, David Khayat, A Baumelou, Philippe Lang, Mario Ollero, André Pawlak, Dil Sahali

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Renal toxicities associated with pembrolizumab

    Renal toxicities associated with pembrolizumab gan Hassan Izzedine, Alexis Mathian, Stéphane Champiat, Cécile Picard, Christine Mateus, Émilie Routier, Andréa Varga, David Malka, Alexandra Léary, Judith Michels, Jean‐Marie Michot, Aurélien Marabelle, Olivier Lambotte, Zahir Amoura, Jean‐Charles Soria, Sihem Kaaki, Nathalie Quellard, Jean‐Michel Goujon, Isabelle Brochériou

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Acute Renal Infarction

    Acute Renal Infarction gan Marie Bourgault, Philippe Grimbert, C. Verret, Jacques Pourrat, M. Herody, Jean‐Michel Halimi, Alexandre Karras, Zahir Amoura, Noémie Jourde‐Chiche, Hassan Izzedine, Arnaud François, Jean‐Jacques Boffa, Aurélie Hummel, P. Bernadet-Monrozies, Denis Fouque, Florence Canouï‐Poitrine, Philippe Lang, Éric Daugas, Vincent Audard

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients

    Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients gan Cindy Marques, Julien Carvelli, Lucie Biard, Stanislas Faguer, François Provôt, Marie Matignon, Jean‐Jacques Boffa, Emmanuelle Plaisier, Alexandre Hertig, Maxime Touzot, Olivier Moranne, Xavier Belenfant, Djillali Annane, T. Quéméneur, J. Cadranel, Hassan Izzedine, Nicolas Bréchot, P. Cacoub, Alexis Piedrafita, Noémie Jourde‐Chiche, David Saadoun

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Mutation Update of the<i>CLCN5</i>Gene Responsible for Dent Disease 1

    Mutation Update of the<i>CLCN5</i>Gene Responsible for Dent Disease 1 gan Lamisse Mansour‐Hendili, Anne Blanchard, Nelly Le Pottier, Isabelle Roncelin, Stéphane Lourdel, Cyrielle Tréard, Wendy González, Ariela Vergara‐Jaque, Gilles Morin, Estelle Colin, Muriel Holder‐Espinasse, Justine Bacchetta, Véronique Baudouin, Stéphane L. Benoit, E. Bérard, Guylhène Bourdat-Michel, Karim Bouchireb, Stéphane Burtey, Mathilde Cailliez, Gérard Cardon, C. Cartery, Gérard Champion, Dominique Chauveau, Pierre Cochat, Karin Dahan, Renaud de la Faille, François-Guillaume Debray, Laurenne Dehoux, Georges Deschênes, Éstelle Desport, Olivier Devuyst, Stella M. Dieguez, Francesco Emma, Michel Fischbach, Denis Fouque, Jacques Fourcade, Arnaud François, Brigitte Gilbert‐Dussardier, Thierry Hannedouche, Pascal Houillier, Hassan Izzedine, Marco Janner, Alexandre Karras, Bertrand Knebelmann, Marie-Pierre Lavocat, Sandrine Lemoine, Valériane Leroy, Chantal Loirat, Marie-Alice Macher, Dominique Martin–Coignard, Denis Morin, Patrick Niaudet, Hubert Nivet, François Nobili, Robert Novo, Laurence Faivre, Claire Rigothier, Gwénaëlle Roussey-Kesler, Rémi Salomon, Andreas Schleich, A.L. Sellier-Leclerc, Kenza Soulami, A. Tiple, Tim Ulinski, Philippe Vanhille, Nicole Van Regemorter, Xavier Jeunemaı̂tre, Rosa Vargas‐Poussou

    Cyhoeddwyd 2015
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: